From the Research
Cabergoline is the preferred pharmacological treatment for lactation suppression, due to its effectiveness and safety profile, as demonstrated in the most recent and highest quality study 1.
Lactation Suppression Options
When considering lactation suppression, it's essential to weigh the benefits and risks of various treatments.
- Pharmacological treatments, such as cabergoline, have been shown to be effective in suppressing lactation.
- Non-pharmacological methods, like avoiding breast stimulation and wearing a supportive bra, may also be helpful.
Cabergoline for Lactation Suppression
Cabergoline, a dopamine agonist, has been found to be a safe and effective option for lactation inhibition in postpartum women 1.
- A dose of 1 mg of cabergoline has been shown to achieve the highest rate of complete success in lactation inhibition.
- Cabergoline is associated with fewer rebound symptoms and adverse effects compared to other pharmacological treatments, such as bromocriptine 2.
Safety and Efficacy
The safety and efficacy of cabergoline for lactation suppression have been established in several studies 3, 2, 1.
- Commonly reported adverse effects of cabergoline, such as dizziness, headache, and nausea, are self-limited.
- Cabergoline is generally safe when given to postpartum women either wishing or needing to suppress lactation.
Recommendation
Based on the most recent and highest quality evidence, cabergoline is the recommended treatment for lactation suppression, due to its effectiveness, safety profile, and simplicity of administration 1.